Covid: Vulnerable NHS patients to be offered new drug

Covid: Vulnerable NHS patients to be offered new drug A new Covid drug designed to reduce the risk of vulnerable patients needing hospital treatment will be available on the NHS from today.

Sotrovimab is a monoclonal antibody given as a transfusion to transplant recipients, cancer patients and other high-risk groups.

If given quickly after symptoms develop it is should help prevent people from falling seriously ill with the disease. BBC News

See also:

• Christmas lockdown: Javid does not rule out new restrictions BBC News
• Covid: More measures needed to limit hospitalisations - Sage scientists BBC News
• First estimate of booster jab impact on Omicron BBC News
• Omicron: Sadiq Khan declares major incident in London BBC News
• Covid: 'We're not looking forward to doing it all again' BBC News
• Covid: Omicron now dominant in England - health experts BBC News
• Ros Atkins on… What 2021 taught us about Covid BBC News
• Is UK heading for New Year lockdown? Professor Neil Ferguson: 5,000 Omicron deaths a DAY The Daily Mail
• Around 936,000 people in England had Covid last week, according to official data The Daily Mail
• NHS is forced to drop rules self-isolation rules for vaccinated staff The Daily Mail
• Sajid Javid hits out at unvaccinated for ‘taking up hospital beds’ The Guardian
• Why a UK Omicron wave is dangerous – even if we see mostly mild cases The Guardian
• England hospital units may close as staff revolt over jab mandate, says NHS leader The Guardian
• The science is clear: the case for more Covid restrictions is overwhelming The Guardian
• Covid patients to be treated in virtual wards at home as NHS staff self-isolate due to Omicron variant iNews
• COVID-19: Warning of NHS staffing 'catastrophe' as one in three London workers could be off by January Sky News